首页|Aclysiran,an RNAi therapeutic agent targeting ACLY,treats hypercholesterolemia and atherosclerosis in ApoE-/-mice

Aclysiran,an RNAi therapeutic agent targeting ACLY,treats hypercholesterolemia and atherosclerosis in ApoE-/-mice

扫码查看

AclysiranACLYAtherosclerosis

Meijie Chen、Peter J.Little、Sudong Kong、Maciej Banach、Jianping Weng、Suowen Xu

展开 >

Department of Endocrinology,the First Affiliated Hospital of USTC,Division of Life Sciences and Medicine,University of Science and Technology of China,Hefei 230001,China

Anhui Provincial Key Laboratory of Metabolic Health and Panvascular Diseases,Hefei 230001,China

Department of Pharmacy,Guangzhou Xinhua University,Guangzhou 510520,China

Suzhou Biosyntech Co.,Ltd.,Suzhou 215300,China

Department of Preventive Cardiology and Lipidology,Medical University of Lodz 23(MUL),Lodz 93-338,Poland

展开 >

2024

药学学报(英文版)

药学学报(英文版)

CSTPCD
ISSN:
年,卷(期):2024.14(12)